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CONSPECTUS
In this Account, we describe the use of perfluoropolyether (PFPE)-based materials that are able to
accurately mold and replicate micro- and nanosized features using traditional techniques such as
embossing as well as new techniques that we developed to exploit the exceptional surface
characteristics of fluorinated substrates. Because of the unique partial wetting and nonwetting
characteristics of PFPEs, we were able to go beyond the usual molding and imprint lithography
approaches and have created a technique called PRINT (Particle [or Pattern] Replication In
Nonwetting Templates).
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PRINT is a distinctive “top-down” fabrication technique capable of generating isolated particles,
arrays of particles, and arrays of patterned features for a plethora of applications in both nanomedicine
and materials science. A particular strength of the PRINT technology is the high-resolution molding
of well-defined particles with precise control over size, shape, deformability, and surface chemistry.
The level of replication obtained showcases some of the unique characteristics of PFPE molding
materials. In particular, these materials arise from very low surface energy precursors with positive
spreading coefficients, can be photocured at ambient temperature, and are minimally adhesive,
nonswelling, and conformable. These distinctive features enable the molding of materials with unique
attributes and nanometer resolution that have unprecedented scientific and technological value. For
example, in nanomedicine, the use of PFPE materials with the PRINT technique allows us to design
particles in which we can tailor key therapeutic parameters such as bioavailability, biodistribution,
target-specific cell penetration, and controlled cargo release. Similarly, in materials science, we can
fabricate optical films and lens arrays, replicate complex, naturally occurring objects such as
adenovirus particles, and create 2D patterned arrays of inorganic oxides.
Introduction
Replication of submicrometer features is a challenging materials problem. The past few
decades have witnessed the emergence of soft lithography as an important tool for low cost
pattern replication on the micrometer and nanometer scale.1 Soft lithography uses embossing
and stamping techniques with applied forces as an alternative to photolithography for the
manufacture of integrated circuits and other devices with sub-50 nm feature sizes. Embossing
typically involves the patterning of materials such as polymers, organics, and biological
molecules into continuous arrays of patterned features using molds made from either hard
materials (quartz/glass, glassy polymers) or soft elastomeric materials to generate features that
form on top of an interconnecting flash layer.1–3 The field of soft lithography has traditionally
been dominated by the elastomer poly(dimethylsiloxane) (PDMS).4,5 Despite the advantage
of PDMS for use in soft lithography, it has been shown to suffer from serious drawbacks
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including the fact that it swells in common organic solvents and is known to leave cyclic
silicone derivatives on surfaces being molded or patterned.6 A recent breakthrough by Rolland
et al. exploits the excellent solvent resistance and the inherent release properties of highly
fluorinated perfluoropolyether (PFPE) elastomers as an exceptional molding material.7,8 The
unique range of material properties of PFPE-based elastomers–chemical resistance, extremely
low surface energy, high gas permeability, solvent resistance, high elastic recovery and good
mechanical strength–translates into the ability of PFPEs to mold most organic and aqueous
liquids to generate useful materials in the form of isolated particles, arrays of particles, and
arrays of patterned features for a number of applications in both nanomedicine and materials
science.
Embossing is the process of creating a three-dimensional image or design in paper and in ductile
materials. It is typically accomplished with a combination of heat and pressure. Unlike
embossing, PFPE-based molding opens up unique approaches that exploit wetting, partial
wetting, and nonwetting phenomena instead of relying on heat and pressure associated with
traditional embossing approaches. As a result of the very low surface energy and high gas
permeability of PFPE-based materials, we are able to mold materials by exploiting the ability
to “dead end” fill recessed cavities in PFPE molds with a wide range of organic liquids.
Depending on the exact details of how the filling process is completed (Figure 1), including
the exact nature of the liquid to be molded, we can uniquely fabricate isolated particles, arrays
of particles, and arrays of patterned features using a combination of cavity filling and free
meniscus coating concepts. We have reported the fabrication of features ranging in size from
2 nm to tens of micrometers and have demonstrated that we are able to accurately mold and
replicate nanometer-scale features with a resolution of 0.4 nm.9
In addition to the unprecedented resolution enabled by the use of PFPE-based materials in
molding processes, we find that we can fill recessed cavities within the PFPE molds with most
organic and aqueous liquids without wetting the land area between the cavities (Figure 1). As
such, once the liquid contained in the cavities is solidified, discrete objects in the mold can be
achieved without the formation of the ubiquitous “flash” or “scum” layer. The flash layer is
common to traditional embossing or soft lithography techniques where applied forces are used.
7,8,10,11 With PFPE-based molds, we can fabricate harvestable, flash-free objects or particles
using a process called PRINT (Particle [or Pattern] Replication In Nonwetting Templates). The
PRINT process begins with the formation of a master template, typically an etched silicon
wafer formed using advanced lithographic techniques (Figure 1A), which is coated with a
photocurable liquid PFPE that is evenly distributed across the surface of the master template.
Once the liquid fluoropolymer has completely wet the master template, it is photochemically
cross-linked and subsequently peeled away to generate a precise mold having nanoscale
cavities (Figure 1B). For the fabrication of two-dimensional arrays of particles or free particles,
the PFPE mold is filled with an appropriate liquid via capillary filling without wetting the land
area around the cavities (Figure 1C). The liquid in the mold cavities is then converted to a solid
using a wide range of methods including curing chemistries, evaporation, lyophilization, or
liquid to solid phase transitions (Figure 1E,E’). The resultant particles can be removed from
the mold and transferred to another surface to generate a two-dimensional array or to yield free
particles (Figure 1F,F’,G).
PRINT is unique from the imprint lithography techniques promulgated by Whitesides et al.1,
4,12 in that PRINT uses elastomeric fluoropolymers instead of silicones, which results in three
important distinctions: (i) perfluoropolyether elastomers have a lower surface energy, which
facilitates the selective filling of nanoscale cavities in the mold with almost any organic liquid
without wetting the land area around the cavities, which enables distinct objects or particles to
be formed even at the micro- and nanoscale; (ii) organic liquids do not swell fluoropolymers
as they do silicones, allowing for the fabrication of a wide range of organic particles with
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desired attributes (surface chemistries, degradation characteristics, deformability) (Figure 2);
(iii) the Teflon-like characteristics of the fluoropolymer mold allow the resultant organic
particles to be easily harvested or removed from the mold.
Herein we describe two research areas being pursued by our laboratory; nanoparticles for
therapeutic and imaging applications and nanopatterned films for materials applications.
Preliminary in vitro and in vivo studies using PRINT particles is presented. The use of PRINT
technology in materials applications, such as optical film and lens applications, replication of
naturally occurring objects, and 2D array patterning of inorganic oxides are also discussed.
Nanomedicine
Establishing the interdependency of the size, shape, deformability, and surface chemistry of
micro- and nanoparticles in vitro and in vivo over length scales ranging from cells to tissues to
the entire organism are needed by many different research communities including
environmental regulators, pulmonologists, oncologists, pharmaceutical scientists,
toxicologists, cell biologists and dermatologists. There is a need for definitive answers related
to particle biodistribution maps based on changes in particle size, shape, deformability, and
surface chemistry using “calibration quality” particles. These nanofabricated tools (e.g.,
precisely defined particles) hold significant promise to provide insight into the fundamentals
of cellular and biological processes because they can yield essential insights into the design of
effective vectors for use in nanomedicine. Beyond understanding the biodistribution of
particles delivered via parenteral routes, particle size, shape, deformability, and surface
chemistry should play a very significant role in understanding the mechanisms associated with
particle inhalation, either intentionally for use as a therapeutic or during environmental
exposure.
There is a significant need to establish such definitive bio-distribution maps for nanomaterials.
Heretofore essentially all of what is known about the biodistribution, pharmacokinetics, and
pharmacodynamics of “particles” in vitro and in vivo has been garnered using either ill-defined
particles or systems where there is little control to systematically vary the key interdependent
variables of size, shape, deformability, and surface chemistry. Liposomal systems have been
the focus of many studies over the last 40 years and have led to the “established” understandings
of where nanomaterials partition in vivo, what sizes lead to cellular internalization and tumor
accumulation, for example.13,14 Unfortunately, liposomal systems can be very misleading
probes since they are dynamic, constantly equilibrating, self-assembled entities whose shape
and surface chemistry is ill-defined especially when placed into the biological milieu where
equilibration reactions occur with naturally occurring lipidic membranes. Beyond liposomes,
most all other nanoparticle systems that have been reported have essentially no ability to control
the size or shape of particles in a defined way to determine the design rules for biodistribution
or cellular internalization and intracellular trafficking.10 In addition, there is also no ability
with liposomes and many traditional nanoparticle systems to systematically hold particle size
and shape constant and iterate on the range of surface characteristics such as ligand type, spatial
distribution of ligands, and stoichiometry of the ligands so as to understand the issues of
multifunctional or multiplexed particles. On top of these shortcomings, there is certainly no
way of using traditional particle or liposomal systems to understand how a deformable particle
or object of precisely defined size, shape, and surface chemistry can dynamically circumvent
various biological barriers. Understanding the role that mechanobiology plays as a function of
size, shape, and surface chemistry certainly lies at the core of how biological “particles” like
neutrophils and red blood cells navigate the barriers that confront them.15 Ascertaining
definitive biodistribution maps through the use of precisely defined particle probes containing
appropriate imaging beacons useful for quantification will undoubtedly lead to a set of rules
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that will be of immense use to science and to the application of nanocarriers for improved
human health, treatment, and diagnosis.
PRINT enables a pharmaco-engineering systems approach to the development of the next
generation of delivery systems with programmable, multifunctional capability. The nature of
the PRINT technology takes drug delivery for the first time into the uncharted realm of
engineered drug therapies given its unique approach and versatility. PRINT allows for the
precise control over particle size, shape, composition, cargo, modulus, and surface properties.
PRINT opens up the possibility for key therapeutic parameters such as bioavailability,
biodistribution, target-specific cell penetration and controlled cargo release to be
simultaneously designed into a therapy.
Cellular Uptake Mechanisms of Nontargeted Organic PRINT Particles
By taking advantage of the versatility of the PRINT process, we are able to vary and control
the amount of surface charge, the size, and the shape of “calibration quality” particles to be
internalized to determine the impact these parameters have on the mechanism of cellular
internalization.16 Several studies have addressed the role of shape and size on cellular
internalization.17–19 Using commercial polystyrene microspheres and murine B16F10
melanoma cells, Rejman and co-workers have shown that spheres with a diameter less than
200 nm utilized a clathrin-mediated mechanism for cellular internalization whereas particles
greater than 500 nm were endocytosed using a caveolae-mediated mechanism.18 No
internalization was seen with particles greater than 1 μm. Furthermore, surface charge was
shown to affect particle uptake with net cationically charged particles being internalized by
clathrin-coated pits while anionic particles were endocytosed via caveolae when added to HeLa
cells.20 Thus size and charge play critical roles in determining which endocytic pathway is
used for particle internalization. To our knowledge, few studies have been done on the
intracellular internalization of shape-specific organic nanoparticles.
Given this, a series of PRINT particles were fabricated to characterize the cellular
internalization mechanisms of non-targeted organic nanoparticles as a function of size, shape,
composition, and surface charge (cationic, anionic) in human cervical carcinoma epithelial
(HeLa) cells. We have seen that particle shape greatly affects cellular internalization. Particles
with a diameter of 200 nm and a height of 200 nm (200 nm × 200 nm) were taken up at a slower
rate (1.2% of the cell population/minute) than their nonsymmetrical rod-like 150 nm × 450 nm
counterparts (5.2% of the cell population/minute). We found a strong dependence on surface
charge, where after 1 h of incubation with the HeLa cells, positively charged particles were
internalized by 84% of cells and negatively charged particles were not internalized to any
significant amount (<5%). We showed that all particles tested possessed minimal toxicity, even
at long incubation times (72 h). Transmission electron microscopy (TEM) clearly showed
clathrin-mediated endocytosis as one of many methods of endocytosis for these particles.
The most commonly accepted belief for cellular internalization in the literature suggests that
particles larger than 200 nm will not be internalized by nonphagocytic cells; however, we found
using a range of techniques that cylindrical PRINT particles as large as 1 μm were internalized
into HeLa cells.21–24 To our knowledge this is the first report of the intracellular uptake and
transport of biologically relevant nanoparticles greater than 200 nm into nonphagocytic
mammalian cells. In addition, we find that rod-like, high aspect ratio nanoparticles can be
internalized into nonphagocytic cells much more rapidly and efficiently than would be expected
based on size considerations alone, suggesting a special role associated with the shape of the
particles. We believe the interplay between particle shape and size at constant surface chemistry
will undoubtedly play a role in particle targeting strategies and may even shed some light on
the rationale behind bacterial pathogen sizes and shapes.
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Preliminary Biodistribution Studies of PRINT Particles
Preliminary in vivo studies of PRINT particles have now been conducted. Monodisperse 200
nm × 200 nm PEG-based PRINT particles (78% (w/w) PEG triacrylate, 20% (w/w) PEG
monomethyl ether monomethacrylate, 1% (w/w) 2,2-diethoxyacetophenone, and 1% (w/w)
para-hydroxystyrene) were fabricated and characterized via scanning electron microscopy and
dynamic light scattering.25 Incubation with HeLa cells showed no cytotoxicity, even at high
particle concentrations. The biodistribution and pharmacokinetics of 125I-labeled particles
were studied following intravenous (iv) administration in nontumor bearing C57BL/6J mice.
The 200 nm × 200 nm PRINT particles were distributed mainly in clearance organs (i.e., liver
and spleen) throughout the time course of the study (Figure 3). The degree of particle
accumulation reported in the kidneys, heart, and lungs may over-represent the actual
accumulation since the mice were not perfused to clear these organs of blood. The decline in
PRINT particle concentration in serum as a function of time followed a biexponential decay,
showing characteristic distribution (half-life = 17 min) and elimination phases (half-life = 200
min). The rapid accumulation of the particles in the liver and the spleen, as well as the relatively
short elimination half-life, indicates that after iv administration the particles were quickly
recognized as foreign and removed from systemic circulation by the reticuloendethelial system
(RES). This is not surprising considering that the steric coat on the PRINT particles was only
a 1000 Da poly(ethylene glycol) (PEG) monomethylether. It has been suggested that the
optimal coating for the creation of long-circulating liposomes is 2–5 kDa PEG.26,27 The
shorter PEG chains used in the current particle formulation may not offer a radius of protection
that is sufficient to effectively block the adsorption of opsonic proteins. Once opsonization
occurs, the particles are destined to be cleared by Kupffer cells in the liver and splenic
macrophages.
Imaging Modalities for a Dynamic View of Biodistribution
We have successfully designed PRINT particles that can be conjugated to 64Cu, a long-lived
positron emitter useful for micro-PET/CT imaging. This work, in collaboration with the
Stanford Center for Cancer Nanotechnology Excellence Focused on Therapy Response and
the CalTech/UCLA Institute for Systems Biology Nanosystems Biology Cancer Center, allows
us to monitor the biodistribution of our PRINT particles in vivo in real time (Figure 4). In order
to conduct PET imaging on our PRINT particles, we designed particles with amine handles for
the covalent conjugation of both 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid
(DOTA), a macrocyclic ligand for the complexation of 64Cu, and PEG 5000 g/mol ligands.
These experiments were performed using a PEG ligand density of 8.4 × 105 PEG chains/200
nm particle. The PET images suggest a relatively short half-life with most of the particles
sequestered in the liver. Currently the group is working on increasing the density of PEG
ligands on the surface of the PRINT particles as well as the incorporation of MR contrast agents
as a cargo within PRINT particles to complement the PET/CT results described above.
Materials Science Applications
The generation of high fidelity particles and arrays of nanoscale features afforded by PFPE
molding materials opens up a host of key opportunities in the material science sector. Below
we discuss the use of PFPE molding and PRINT for applications in optical films and lens
arrays, the replication of naturally occurring objects, porous films, and 2D array patterning of
inorganic oxides.
Molding of High Performance Optical Films and Lens Arrays
Imprint lithography is a common tool used to fabricate micro- and nanopatterned embossed
films or isolated features for use in photonic and optoelectronic devices.2,3,28–30 These
patterned films require microscale feature sizes with subpatterns of nanoscale precision for
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surfaces, edges, corners, spacing, and angles for effective light manipulation. Imprint
lithography has the potential as a cost-effective alternative to photolithography for
manufacturing highly precise optical components and other patterned films and membranes
with submicrometer features.31,32 However, PRINT is different from traditional imprint
lithography since no pressure is applied. The utilization of the PRINT process with a wide
variety of optical materials has been demonstrated in batch scale using UV-curable optical
resins, conducting polymers, and inorganic oxides.33
Figure 5 shows the fabrication of 70 nm × 70 nm cylindrical features patterned on a glass
substrate out of a material whose index of refraction is equivalent to that of the substrate along
with the transmission of s-polarized light through the sample. The nanostructured sample
shows an increase in transmission for the entire visible spectrum relative to a flat film of the
same material. In addition to patterning monoclonal features across a substrate, PRINT is also
capable of fabricating features of different size, shape, aspect ratio, and packing density in a
single step. Figure 6A is an optical picture of an 8-inch diameter film with five different patterns
prepared in a single-step via PRINT. Figure 6B–F shows high-resolution SEM images of the
five different areas, depicting the micro- and nanoscale precision of the PRINT process
throughout a large area.
Fabrication of Ultra-monodisperse Micro- and Nanoporous Thin Films
Nanoporous and mesoporous polymeric films are used in a variety of applications such as
separations, filtrations, sensors, photonics, optoelectronics, bioactive surfaces, waveguides,
and absorbants.34–37 PRINT’s “top-down” approach allows for the fabrication of micro- and
nanoporous membranes with nanometer precision of pore size and shape with the concomitant
effect of being able to engineer membranes using a wide variety of high-performance polymers.
Traditional “bottom-up” techniques used to fabricate nanoporous membranes such as cast
membrane phase inversion,38 solvent extraction,39 and block copolymer phase
separation40,41 have resulted in polydisperse pores or little flexibility in the membrane
material. Figure 7 depicts SEM images of microporous membranes fabricated out of PDMS
(Sylgard 184), PEG-diacrylate, and the high-performance polymer poly(arylene ether sulfone),
showcasing the size and shape control along with the chemical variability of PRINT as a
membrane fabrication process.42
Replication of Naturally Occurring Objects
The low surface energy, minimally adhesive, low-viscosity, ambient-temperature photocurable
PFPE elastomers enable the replication of naturally occurring objects.9 Here, the PFPE liquid
precursor is able to be cast over a naturally occurring motif and cured to form an elastomeric
mold with the details of the master morphology embedded in the fluoropolymer matrix. The
PFPE molding material enables the molding of isolated, weakly adhering, and, in some cases,
metastable “soft” nanoscale objects. The PFPE mold can then be used to make replicate objects
of the naturally occurring masters in a variety of materials with high fidelity. The molding
process has been used to replicate carbon nanotubes, block-copolymer micelles, and virus
particles (Figures 8 and 9).
Figure 8 depicts the replication of self-assembled spherical micelles, cylindrical micelles, and
metastable toroidal morphologies. Since the micelles are lying on the mica substrate, only one
side of the micellar structure is available for molding and replication. The micelles are
particularly fragile structures, because they are only held together by noncovalent forces and
are freely lying on the substrate. The toroidal morphology shown in Figure 8H–J, formed during
the transition from cylindrical micelles to vesicles,43 is a metastable morphology that was able
to be captured in a PFPE mold and replicated into more stable materials. These structures, for
which the “hole” in the toroid has a diameter of less than 20 nm, could potentially be used as
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masks for etching techniques to generate nanoscale features in another material with interesting
optical, electronic, or magnetic properties.44
The ability to replicate biological structures may provide crucial insight into the importance
of shape in biology and lead to advantageous new platforms for imaging and immunotherapies,
particularly if chemical cues can simultaneously be incorporated with these biologically
derived structure. Figure 9 shows the molding and replication of dispersed adenoviruses on a
silicon surface. We were successfully able to replicate the viruses without degradation of the
original adenovirus particles, thus further demonstrating the chemical inertness of the PFPE
molding process.
Submicrometer Patterning of Inorganic Oxides
We explicitly use the low surface energy and high gas permeability of cross-linked PFPE-based
materials to demonstrate the chemical inertness of fluoroelastomers and have illustrated the
use of aggressive chemistries during the embossing and PRINT processes that enable the
formation of uniquely patterned, sub-500 nm size, inorganic oxide materials with potential
utility in electronic and optical devices.45–48 A range of oxides including SnO2, ZnO, ITO
(Sn-doped indium oxide), and BaTiO3 have been formed into arrays with precise control over
size, shape, and composition (see Figure 10). Figure 11 shows high aspect ratio TiO2 features
derived from a sol–gel solution patterned from a 200 nm × 600 nm PFPE mold on an ITO
coated glass substrate. The patterns are able to be formed on both insulating (glass) and
conducting substrates (ITO and FTO coated glass slides). It should be noted that when
structures are patterned through a sol–gel method, volume loss relative to the original template
occurs; however the shrinkage is able to be controlled by varying the initial sol–gel chemistry
and annealing rates. There is much interest in nanopatterns of titania for use in titania–polymer
solar cells, where a high degree of order and reproducibility is needed to form the desired ideal
bulk heterojunction.49,50
Summary
In this Account, we have introduced the concept of PRINT, a powerful new particle molding,
pattern generation, and replication technique that takes advantage of the unique properties of
PFPE elastomeric molds. The low surface energy perfluoropolyether network allows for the
production of monodisperse, shape-specific micro- and nanoparticles from an extensive array
of precursors and the generation of high-fidelity patterns for a wide variety of materials
applications.
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Schematic illustration of the PRINT process and traditional embossing processes: (A) silicon
master template; (B) mold release from master template; (C) mold filling via capillary fill with
countersheet having a higher surface energy than the PFPE mold; depending on the exact nature
of the liquid to be molded and the details of the process, (D) one can fill the cavities only and
not wet the land area around the cavities or (D’) one can fill the cavities and have a thin layer
of liquid on the land area around the cavities. The thickness of the layer of connecting flash
layer liquid is determined from the principles associated with free meniscus coating processes
with the resulting (E, E’) pattern transfer to substrate, (F, F’) mold release from array of isolated
features, and (G) dissolution of the harvesting film to yield free particles. As an alternative to
PRINT, one can use PFPEs using traditional embossing processes where pressure and heat are
applied (H, I) to form an embossed film (J) after the mold is removed.
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PRINT particles varying in size, shape, surface chemistry, and deformability. The particle
composition for all of these particles was approximately the same and included PEG (bulk of
the matrix), a cross-linker, and a linker group for conjugation of stabilizing groups (such as
PEG) or targeting ligands (such as peptides, antibodies, etc): (A) scanning electron micrograph
(SEM) of cube-shaped particles with a cube side length of 5 μm; (B) SEM of cylindrical
nanoparticles having diameter = 110 nm and height = 35 nm; (C) SEM of cylindrical
nanoparticles having diameter = 200 nm and height = 200 nm; (D) SEM of rod-like PRINT
particles having diameter = 100 nm and height = 300 nm; (E) SEM of 3 μm “hex nut” particles;
(F) cylindrical PRINT particles containing a covalently attached red fluorophore that have been
functionalized on one face with a generic linker group (green fluorophore) that will allow the
conjugation of targeting peptides, antibodies, and aptamers region-specifically onto the particle
probes; (G, H) particles for mechanobiology studies having approximately the same
dimensions as red blood cells (cylinders with a diameter = 7 μm and a height of 1.7 μm made
from (G) a nondeformable, highly cross-linked hydrogel and (H) lightly cross-linked,
deformable hydrogel.
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Biodistribution of 200 nm [125I]-labeled PEG 1K PRINT particles in healthy mice. The organ
accumulation is expressed as a percent of injected dose. The organ data is presented as the
mean ± SD with n = 4. Reprinted with permission from ref 25. Copyright 2007 Elsevier.
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MicroPET imaging with 64Cu-DOTA PRINT particles. Time-resolved PET images consist of
a 2 h dynamic scan. The PET/CT images are overlaid. The mouse was injected with 136.2
μCi of 64Cu-labeled DOTA-nanoparticle. Both the coronal view (top), and sagittal view
(bottom) are presented.
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AFM image of 70 nm features on glass and transmission of s-polarized light.
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Picture of an 8-in. substrate with (A) five different patterns and (B–F) SEM images of the
individual features.
GRATTON et al. Page 18














PDMS (Sylgard 184) membranes containing 3 μm diameter pores of monodisperse quality
(left), PEG-diacrylate cross-linked monodisperse 3 μm diameter pore membranes (middle),
and poly(arlene ether sulfone) 5 μm diameter porous membranes based on biphenol and
dichlorodiphenyl sulfone monomers (right).
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Polystyrene-block-polyisoprene (PS-b-PI) micelle replication. Depending on the block-
copolymer composition, self-assembly of PS-b-PI in heptane results in micelles with well-
defined shapes: (A) schematic image depicting self-assembly of micelles and their deposition
onto substrates (brown/white), molding (green/black), and replication (blue/magenta); (B)
spherical micelle master, prepared by self-assembly of a 39 kDa-b-94 kDa PS-b-PI copolymer
and solution deposition onto mica (vertical scale = 100 nm); (C) PFPE mold of a spherical
micelle master (vertical scale = 20 nm); (D) triacrylate replica of spherical micelles (vertical
scale = 130 nm); (E) cylindrical micelle master, prepared by self-assembly of a 40 kDa-b-10
kDa PS-b-PI copolymer and solution deposition onto mica (vertical scale = 300 nm); (F) PFPE
mold of a cylindrical micelle master (vertical scale = 200 nm) (G) triacrylate replica of
cylindrical micelles (vertical scale = 300 nm); (H) toroidal micelle master, prepared by self-
assembly and deposition of a 21 kDa-b-4 kDa PS-b-PI copolymer and solution deposition onto
mica (vertical scale = 45 nm); inset, larger AFM image showing a collection of toroidal micelle
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nano-objects (vertical scale = 150 nm); (I) PFPE mold of a toroidal micelle (vertical scale =
25 nm); (J) triacrylate replica of a toroidal micelle master (vertical scale = 60 nm). Reprinted
with permission from ref 9. Copyright 2007 Wiley-VCH.
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(A) AFM image of an adenovirus master, prepared by depositing adenovirus particles onto a
silicon surface (vertical scale = 100 nm), (B) AFM image of a PFPE mold formed from an
adenovirus master (vertical scale = 50 nm), (C) AFM image of a triacrylate/bisphenol A
dimethacrylate adenovirus replica (vertical scale = 100 nm), (D) transmission electron
microtomography (TEMT) reconstruction of a triacrylate/bisphenol A dimethacrylate
adenovirus replica, and (E) cryo-electron microscopy reconstruction of adenovirus. Reprinted
with permission from ref 9. Copyright 2007 Wiley-VCH.
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Arrays of features on glass made from a 200 nm × 200 nm mold in (A) SnO2, (B) ZnO, (C)
ITO, and (D) BaTiO3. Reprinted with permission from ref 48. Copyright 2008 Wiley-VCH.
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Array of 200 nm × 600 nm anatase TiO2 features. Reprinted with permission from ref 48.
Copyright 2008 Wiley-VCH.
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